Independent guide to finasteride. Not a pharmacy and not a telehealth company.

Topical finasteride

By the Finasteride.com editorial team. Sources are listed at the end of the page.

Short answerTopical finasteride is a liquid, spray or gel form of the drug applied to the scalp, and in the US it is made by compounding pharmacies because the FDA has not approved any topical version. One phase III trial found a spray improved hair count about as much as the 1 mg tablet with far less drug in the blood, but it is still absorbed and side effects have been reported.
Where to get it

Finasteride needs a prescription. These providers issue one online.

Compare all providersNot sure? Take the 1-minute quiz

What topical finasteride is

Topical finasteride is finasteride dissolved in a solution, spray or gel and applied directly to the thinning scalp. The aim is to lower DHT (the hormone that shrinks hair follicles) in the scalp while exposing the rest of the body to less of the drug than a tablet does. It is often mixed with minoxidil in a single product. Background on the hormone is on the how it works page.

Compounded, not FDA-approved

No topical finasteride product is approved by the FDA, alone or combined with another ingredient. The only approved forms are the tablets, Propecia and Proscar. Topical versions sold in the US are compounded, meaning a pharmacy mixes them to order. Compounded drugs are legal to prescribe, but the FDA does not review them for safety, effectiveness or quality before they are sold, and they come without FDA-approved labeling. Formulas also differ from one pharmacy to another.

In April 2025 the FDA issued an alert about compounded topical finasteride. It had received 32 reports of side effects between 2019 and 2024, and said most described symptoms that continued after the product was stopped.

What the phase III trial found

The best evidence is a 24-week phase III trial published by Piraccini and colleagues in 2022, which found the spray beat placebo and looked similar to the tablet. The study randomized 458 men at 45 sites in Europe to a finasteride spray, a placebo spray, or oral finasteride. At week 24, the hair count in the target area had risen by 20.2 hairs with the topical spray and 6.7 with placebo. The change with the spray was described as numerically similar to the change with oral finasteride. Side effects and dropouts did not differ meaningfully between the spray and placebo.

Two limits matter. The trial lasted 24 weeks, while oral finasteride has five years of controlled data. And it tested one manufacturer's spray, not the compounded products sold in the US.

How much reaches the bloodstream

Less finasteride reaches the blood with a topical product, but it is not zero, and the amount depends on the formula and dose. In the phase III trial, peak blood levels of finasteride were more than 100 times lower with the spray than with the tablet. Blood DHT still fell by 34.5% with the spray, compared with 55.6% with the tablet. An earlier study of a different product, a 0.25% solution applied twice a day for a week, lowered blood DHT by about 68 to 75%, similar to the tablet in the same study.

The FDA alert says absorption through the skin into the bloodstream is expected, and the reports it received described the same kinds of problems seen with tablets, including erectile dysfunction, low libido, depression and anxiety. See side effects.

Topical versus oral, and use with minoxidil

Oral finasteride has stronger and longer evidence, and topical finasteride offers lower drug levels in the blood with less proof. The tablet is FDA-approved, standardized and supported by large trials. Topical products add two risks of their own that the FDA names: local reactions such as irritation, redness, dryness, stinging and burning, and transfer of the drug to other people by contact. That second point matters most around pregnancy, since finasteride can harm a male fetus (see finasteride and women).

Combination sprays with minoxidil are widely marketed, and the two drugs work in different ways, but the combined products themselves have little controlled evidence in men. The evidence for pairing the two drugs is covered under combinations.

Common questions

Is topical finasteride FDA-approved?

No. The FDA states there is no approved topical formulation of finasteride. Products sold in the US are compounded.

Does topical finasteride have fewer side effects than the pill?

It puts less drug in the blood, and in the phase III trial side effects were similar to placebo over 24 weeks. The FDA has still received reports of sexual and mood side effects with compounded topical products.

Does topical finasteride work as well as oral?

In one 24-week trial the hair count gain was similar. There are no long-term comparisons, and compounded formulas have not been tested the same way.

Can a partner be exposed to topical finasteride?

Yes. The FDA notes a greater risk of transferring the drug to others with topical products. Let it dry, wash your hands, and take extra care if a partner is or may be pregnant.

Sources

  1. US Food and Drug Administration. FDA alerts health care providers, compounders and consumers of potential risks associated with compounded topical finasteride products, 2025. FDA alert
  2. Piraccini BM, Blume-Peytavi U, Scarci F, et al. Efficacy and safety of topical finasteride spray solution for male androgenetic alopecia: a phase III, randomized, controlled clinical trial. Journal of the European Academy of Dermatology and Venereology, 2022. PubMed 34634163
  3. Caserini M, Radicioni M, Leuratti C, et al. A novel finasteride 0.25% topical solution for androgenetic alopecia: pharmacokinetics and effects on plasma androgen levels in healthy male volunteers. International Journal of Clinical Pharmacology and Therapeutics, 2014. PubMed 25074865
  4. Organon. Propecia (finasteride) tablets 1 mg, full prescribing information and patient information. DailyMed, National Library of Medicine. DailyMed: Propecia label
Compare finasteride providers